At the time, she wasn't sure what specialty she wanted to pursue, but her own medical experience guided her. "I had a hard ...

What do federal funding cuts mean for MS researchers and those living with the disease? Then, should you kiss your dentist ...

To provide the right treatment for multiple sclerosis (MS), it is important to know when the disease changes from relapsing-remitting to secondary progressive, a transition that is currently ...

The patent comes months after Immunic Therapeutics announced CALLIPER study results, which tested vidofludimus calcium in ...

The first signs of multiple sclerosis (MS) may appear much earlier than most doctors once believed. A new study suggests that ...

—Investigators conducted an analysis using self-reported data from European multiple sclerosis patients to assess the prevalence of bladder problems and their impact on well-being. Share on Facebook.

Resistance training is effective for improving gait speed in individuals with multiple sclerosis. The intensity and duration of resistance training are important factors in determining the magnitude ...

Ocrevus rapidly depletes immune B-cells in people with MS, but ongoing treatment also leads to changes in immune T-cells, a ...

BRIUMVI is indicated in the U.S. for the treatment of adults with RMS, including clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease and in the EU and ...

Newly approved multiple sclerosis drug given to first U.S. patients today in Cullman Novartis multiple sclerosis drug investigated after 11 deaths, 1 in U.S.